Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Biogen at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Biogen brings 1 presentation to ASH 2026 in New Orleans, and exhibits at Booth 2934. Its research centres on treating paroxysmal nocturnal hemoglobinuria in teenagers. It covers pegcetacoplan dosing, efficacy and safety in a phase 2 trial.

OrganizationASH 2026 Attendance
Biogen
Cambridge, MA
Large pharma
Biotechnology company founded in 1978 that develops and sells medicines; it agreed in 2026 to buy Apellis Pharmaceuticals.
Booth
Exhibiting at Booth 2934
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Biogen

Tell us what you sell and we’ll find the people at Biogen most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction